Clozapine treatment and risk of COVID-19

The antipsychotic clozapine is known to have immune-modulating effects. Clozapine treatment has been reported to be associated with increased risk of COVID-19 infection. However, it remains unclear whether this is because of increased testing of this patient group, who are closely monitored. We link...

Descripción completa

Detalles Bibliográficos
Autores principales: Osimo, Emanuele F., Lewis, Jonathan, Cardinal, Rudolf N., Khandaker, Golam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273724/
https://www.ncbi.nlm.nih.gov/pubmed/35815763
http://dx.doi.org/10.1192/bjo.2022.537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273724/
https://www.ncbi.nlm.nih.gov/pubmed/35815763
http://dx.doi.org/10.1192/bjo.2022.537

Ejemplares similares